ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135073 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135073; 2) Community: the network communities that were significantly associated with the response to NSC 135073; 3) Molecule: the relationships between components within communities and NSC 135073; 4) MDR: the compounds that were significantly associated with the NSC 135073.

NSC Compound Enrichment Correlation
NSC 623436 TGF.alpha.-PE40 0.0171490505199911 -0.31355596
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.0171490505199911 0.74139168
NSC 624153 Null 0.0171490505199911 0.47631776
NSC 639187 Landomycin A 0.0171490505199911 0.71539104
NSC 655748 Null 0.0171490505199911 0.53455124
NSC 659936 Null 0.0171490505199911 0.51810116
NSC 661415 2-Chloro-3-(2-butoxyethoxy)naphthazarin 0.0171490505199911 0.68278812
NSC 666113 Null 0.0171490505199911 0.59928475
NSC 679002 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- 0.0171490505199911 0.72005307
NSC 702047 2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(2-furanyl)- 0.0171490505199911 0.60521047
Total:99  Current:49    [First] [Prev] [Next] [Last]